Etelcalcetide

Brand Name(s):Parsabiv

Indication:Hyperparathyroidism, secondary (SHPT) in adult patients with chronic kidney disease (CKD) on haemodialysis therapy.

Rationale:1,2,3

Considered:Nov-16

Review Date:Jan-22